- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01819493
Parents and Children Together Preventing Diabetes (PACT PD) (PACT PD)
Parents and Children Together Preventing Diabetes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest Baptist Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Body Mass index (One overweight/obese parent (25 kg/m2 <BMI<40 kg/m2 and one overweight/obese child (at or above the 85th% of age-and gender- specific BMI)
- Parental HbA1c levels (pre-diabetes = 5.7 - 6.4%)
- Parent and their child age 8-10
Exclusion Criteria:
- Clinical history of T2DM
- On glucose-lowering drugs
- Currently participating in a supervised weight loss program
- Pregnant or Breastfeeding
- Has conditions limiting participation in the interventions
- Has undergone weight loss surgery
- Unwilling to accept randomization
- Plans to live outside the general area in the next 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard Family-Based intervention
Families randomized to the Standard Family-based Intervention will receive three-month family YMCA memberships, one orientation training session, access to available equipment and programming at the YMCA, and receive diabetes educational materials from the "Power to Prevent" curriculum via email.
Based on our previous experience with AA adults, the investigators anticipate that all families will have access to email either at home or at work.
Educational materials will be mailed to families without access to email.
The study will also maintain contact with participants by sending holiday and birthday cards, as well as postcard reminders of scheduled data collection visits.
|
Comparison intervention
|
|
Experimental: Lifestyle Intervention
The lifestyle intervention for adults will involve a dietary weight loss program and an increase in caloric expenditure through moderate PA. Parents will be encouraged to decrease caloric intake in a sound manner to produce a total weight loss of 5%. The PA component will be to promote an increase in family home-based activity. Children. The study will promote healthy eating behaviors, rather than restrictive eating plans with caloric restrictions. |
Family-based group lifestyle intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Mass Index
Time Frame: 12 weeks and 16 weeks.
|
The study will assess change in body mass index in both parents and children at 2 post-randomization time points.
We will compare these with baseline BMI.
|
12 weeks and 16 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Waist Circumference
Time Frame: 12 weeks and 16 weeks.
|
12 weeks and 16 weeks.
|
|
|
Physical activity
Time Frame: 12 weeks and 16 weeks
|
The study will measure physical activity in parents and children by accelerometry.
|
12 weeks and 16 weeks
|
|
Dietary Intake
Time Frame: 12 weeks and 16 weeks
|
The study will use BLOCK measures for both children and parents to assess dietary intake.
|
12 weeks and 16 weeks
|
|
Blood Pressure
Time Frame: 12 weeks and 16 weeks
|
12 weeks and 16 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Bettina Beech, DrPH, Wake Forest University
- Principal Investigator: Edward Ip, PhD, Wake Forest University Health Sciences
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00021267
- R34DK094108-01A1 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.